BACKGROUND: Papua New Guinea has among the highest prevalence of sexually transmitted infections in the world but no estimates of Chlamydia trachomatis, Neisseria gonorrhoeae, or hepatitis B virus (HBV) are available among men who have sex with men (MSM) or transgender women (TGW). METHODS: We conducted respondent-driven sampling surveys among MSM and TGW in Port Moresby, Lae, and Mt Hagen (2016-2017) to characterize the prevalence of these infections. Eligibility criteria were as follows: aged ≥12 years, born male, could speak English or Tok Pisin, and had oral or anal sex with another person born male in the past 6 months. Participants were surveyed face-to-face and offered testing for anorectal and genital chlamydia and gonorrhea, syphilis, HIV, and HBV. All results are respondent-driven sampling weighted. RESULTS: We enrolled 400 participants in Port Moresby, 352 in Lae, and 111 in Mt Hagen. Chlamydia prevalence rates in the 3 cities regardless of anatomical site were 19.9%, 19.2%, and 24.3%, respectively. Gonorrhea prevalence rates regardless of anatomical site were 10.3%, 9.4%, and 9.6%, respectively. Hepatitis B virus prevalence rates were 11.7%, 13.8%, and 13.6%, respectively. In multivariable analysis, syphilis was associated with having either chlamydia or gonorrhea in Port Moresby (adjusted odds ratio, 4.0; 95% confidence interval, 2.0-7.9) and Lae (adjusted odds ratio, 2.4; 95% confidence interval, 1.2-5.0). CONCLUSIONS: There is a large unmet need among MSM and TGW in Papua New Guinea for chlamydia and gonorrhea detection and treatment. The high prevalence of HBV reinforces the importance of ensuring introduction and scale-up of HBV treatment and immunization. Urgent efforts are needed to introduce laboratory-based diagnosis for chlamydia and gonorrhea to ensure these populations have access to much needed treatment services.
BACKGROUND: Papua New Guinea has among the highest prevalence of sexually transmitted infections in the world but no estimates of Chlamydia trachomatis, Neisseria gonorrhoeae, or hepatitis B virus (HBV) are available among men who have sex with men (MSM) or transgender women (TGW). METHODS: We conducted respondent-driven sampling surveys among MSM and TGW in Port Moresby, Lae, and Mt Hagen (2016-2017) to characterize the prevalence of these infections. Eligibility criteria were as follows: aged ≥12 years, born male, could speak English or Tok Pisin, and had oral or anal sex with another person born male in the past 6 months. Participants were surveyed face-to-face and offered testing for anorectal and genital chlamydia and gonorrhea, syphilis, HIV, and HBV. All results are respondent-driven sampling weighted. RESULTS: We enrolled 400 participants in Port Moresby, 352 in Lae, and 111 in Mt Hagen. Chlamydia prevalence rates in the 3 cities regardless of anatomical site were 19.9%, 19.2%, and 24.3%, respectively. Gonorrhea prevalence rates regardless of anatomical site were 10.3%, 9.4%, and 9.6%, respectively. Hepatitis B virus prevalence rates were 11.7%, 13.8%, and 13.6%, respectively. In multivariable analysis, syphilis was associated with having either chlamydia or gonorrhea in Port Moresby (adjusted odds ratio, 4.0; 95% confidence interval, 2.0-7.9) and Lae (adjusted odds ratio, 2.4; 95% confidence interval, 1.2-5.0). CONCLUSIONS: There is a large unmet need among MSM and TGW in Papua New Guinea for chlamydia and gonorrhea detection and treatment. The high prevalence of HBV reinforces the importance of ensuring introduction and scale-up of HBV treatment and immunization. Urgent efforts are needed to introduce laboratory-based diagnosis for chlamydia and gonorrhea to ensure these populations have access to much needed treatment services.
Authors: M S Cohen; I F Hoffman; R A Royce; P Kazembe; J R Dyer; C C Daly; D Zimba; P L Vernazza; M Maida; S A Fiscus; J J Eron Journal: Lancet Date: 1997-06-28 Impact factor: 79.321
Authors: Magnus Unemo; Catriona S Bradshaw; Jane S Hocking; Henry J C de Vries; Suzanna C Francis; David Mabey; Jeanne M Marrazzo; Gerard J B Sonder; Jane R Schwebke; Elske Hoornenborg; Rosanna W Peeling; Susan S Philip; Nicola Low; Christopher K Fairley Journal: Lancet Infect Dis Date: 2017-07-09 Impact factor: 25.071
Authors: Avi J Hakim; Steven G Badman; Damian Weikum; Angelyne Amos; Barne Willie; Rebecca Narokobi; Josephine Gabuzzi; Simon Pekon; Martha Kupul; Parker Hou; Herick Aeno; Ruthy Neo Boli; Joshua Nembari; Sophie Ase; John M Kaldor; Andrew J Vallely; Angela Kelly-Hanku Journal: Sex Transm Infect Date: 2019-06-10 Impact factor: 3.519
Authors: Angela Kelly; Martha Kupul; Richard Nake Trumb; Herick Aeno; James Neo; Lisa Fitzgerald; Peter S Hill; John M Kaldor; Peter Siba; Andrew Vallely Journal: BMC Int Health Hum Rights Date: 2012-07-20
Authors: Andrew Vallely; Andrew Page; Shannon Dias; Peter Siba; Tony Lupiwa; Greg Law; John Millan; David P Wilson; John M Murray; Michael Toole; John M Kaldor Journal: PLoS One Date: 2010-12-23 Impact factor: 3.240
Authors: Avi J Hakim; Kelsey Coy; Steven G Badman; Barne Willie; Rebecca Narokobi; Josephine Gabuzzi; Simon Pekon; Martha Kupul; Parker Hou; Herick Aeno; Ruthy Neo Boli; Joshua Nembari; Sophie Ase; Angelyne Amos; Nick Dala; Damian Weikum; Steven Callens; John M Kaldor; Andrew J Vallely; Angela Kelly-Hanku Journal: BMC Public Health Date: 2019-05-22 Impact factor: 3.295